Rockefeller Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-18
| Closed | – | – | 3667 |
|
|
2022
Q4 | $0 | Hold |
18
| – | – | ﹤0.01% | 4197 |
|
|
2022
Q3 | $0 | Sell |
18
-124
| -87% | – | ﹤0.01% | 4352 |
|
|
2022
Q2 | $4K | Buy |
142
+59
| +71% | +$1.66K | ﹤0.01% | 3574 |
|
|
2022
Q1 | $2K | Sell |
83
-248
| -75% | -$5.98K | ﹤0.01% | 3640 |
|
|
2021
Q4 | $9K | Buy |
+331
| New | +$9K | ﹤0.01% | 3038 |
|
|
2020
Q4 | – | Sell |
-315
| Closed | -$6K | – | 3001 |
|
|
2020
Q3 | $6K | Buy |
315
+64
| +25% | +$1.22K | ﹤0.01% | 2179 |
|
|
2020
Q2 | $6K | Sell |
251
-202
| -45% | -$4.83K | ﹤0.01% | 2060 |
|
|
2020
Q1 | $8K | Buy |
453
+323
| +248% | +$5.7K | ﹤0.01% | 1827 |
|
|
2019
Q4 | $3K | Sell |
130
-1,163
| -90% | -$26.8K | ﹤0.01% | 1880 |
|
|
2019
Q3 | $36K | Sell |
1,293
-30
| -2% | -$835 | ﹤0.01% | 1070 |
|
|
2019
Q2 | $44K | Buy |
1,323
+241
| +22% | +$8.02K | ﹤0.01% | 837 |
|
|
2019
Q1 | $38K | Buy |
1,082
+757
| +233% | +$26.6K | ﹤0.01% | 999 |
|
|
2018
Q4 | $11K | Hold |
325
| – | – | ﹤0.01% | 689 |
|
|
2018
Q3 | $16K | Hold |
325
| – | – | ﹤0.01% | 533 |
|
|
2018
Q2 | $19K | Buy |
+325
| New | +$19K | ﹤0.01% | 536 |
|